000			02001 a2200553 4500
005			20250513190559.0
264		0	_c19990831
008			199908s 0 0 eng d
022			_a0002-9440
024	7		_a10.1016/s0002-9440(10)65149-8 _2doi
040			_aNLM _beng _cNLM
100	1		_aBellone, G
245	0	0	_aTumor-associated transforming growth factor-beta and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients. _h[electronic resource]
260			_bThe American journal of pathology _cAug 1999
300			_a537-47 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdenocarcinoma _ximmunology
650	0	4	_aAged
650	0	4	_aAntibodies, Monoclonal
650	0	4	_aCulture Media, Conditioned _xpharmacology
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImmunophenotyping
650	0	4	_aInterferon-gamma _xantagonists & inhibitors
650	0	4	_aInterleukin-10 _xbiosynthesis
650	0	4	_aInterleukin-12 _xantagonists & inhibitors
650	0	4	_aKiller Cells, Lymphokine-Activated _ximmunology
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPancreatic Ducts _xpathology
650	0	4	_aPancreatic Neoplasms _ximmunology
650	0	4	_aReverse Transcriptase Polymerase Chain Reaction
650	0	4	_aT-Lymphocytes _ximmunology
650	0	4	_aTh1 Cells _ximmunology
650	0	4	_aTh2 Cells _ximmunology
650	0	4	_aTransforming Growth Factor beta _xbiosynthesis
650	0	4	_aTumor Cells, Cultured
700	1		_aTurletti, A
700	1		_aArtusio, E
700	1		_aMareschi, K
700	1		_aCarbone, A
700	1		_aTibaudi, D
700	1		_aRobecchi, A
700	1		_aEmanuelli, G
700	1		_aRodeck, U
773	0		_tThe American journal of pathology _gvol. 155 _gno. 2 _gp. 537-47
856	4	0	_uhttps://doi.org/10.1016/s0002-9440(10)65149-8 _zAvailable from publisher's website
999			_c10391726 _d10391726